An Observational Study of the Risk of Acute Pancreatitis in Subjects Exposed to Albiglutide, Other GLP-1 Agonists or DPP-4 Inhibitors Compared to Other Antidiabetic Agents (201804) First published 27/01/2016 Last updated 18/04/2024 EU PAS number:EUPAS11845 Study Finalised